Hormonal Claira: instructions for use and side effects of the drug

The drug "Clayra" continues a number of combined oral contraceptives. The most important functions of the drug are suppression of the ovulation process and influence on the properties of cervical mucus. In addition to preventing pregnancy, the drug has a number of positive properties, which makes it prevalent when a woman chooses contraceptives. Among the positive qualities, it is worth highlighting the decrease in intensity and soreness in women, which appears on time menstrual like flushes. As a result, the possibility of iron deficiency development decreases in patients. In medical studies, there is evidence of a reduction in the likelihood of developing ovarian cancer and endometrium in women.

The coated tablets are the only form of release of the drug "Clayra". Instructions for use indicate that one blister of the drug contains 28 tablets of different shapes and colors: 2 dark yellow, red and white, 5 pink and 17 pale yellow tablets. Each blister is pasted into a clamshell book, which, in addition to the medicine, contains a self-adhesive calendar for taking the drug and instructions for it.

The drug "Clayra" as an estrogen contains estradiol valerate, which, unlike its predecessors, has a higher ability to metabolize and to a lesser extent affects the liver. Denoting the positive effects of the drug, we can say that it is the first contraceptive, which includes estrogen, almost identical to the natural, which is a welcome discovery in the field of contraception.

Medicinal preparation "Clayra": instructions for use. Contraindications

The only indication for the use of the drug is to prevent pregnancy. There are a number of contraindications to the use of the drug "Clayra". The instructions for use warn you that if you have one of the following tablets, you can not take it:

- Thrombosis (venous and arterial), myocardial infarction, thromboembolism (and at this time, and in the anamnesis);

- ischemia, stenocardia (in history including);

- the presence of many factors that are the precursors of thrombosis;

- diabetes;

- migraine with severe neurologic abnormalities;

- pancreatitis;

- liver disease;

- malignant or benign liver tumors ;

- detected tumors (malignant hormone-dependent);

- vaginal bleeding (of unknown origin);

- Suspicion of pregnancy and pregnancy ;

- sensitivity to the components of the drug.

The drug "Clayra": side effects

There are a number of special instructions for the Clare contraceptive. Instruction for use warns of the possibility of side effects of the drug in the event of ignoring at least one of the listed characteristics:

- t the rhombus . Women taking the drug increase the risk of developing thrombosis, although it is not as large as that of pregnant women. It is recommended to stop smoking during the period of drug use, especially for women whose age has exceeded 35 years. The doctor can prohibit taking the drug if the patient is already done or is about to undergo surgery, because the risk of developing thrombosis increases with a fixed lifestyle. The same advice will follow if a woman has high blood pressure.

- Tumors.   Against the background of hormonal   In some cases, there is a development of not only benign tumors. It is extremely rare, but there were patients with developing malignant lesions in the liver, which carries a risk to life and the risk of internal bleeding.

- reduction in the degree of efficiency.   To maintain the effectiveness of the drug "Clayra" at a high level, the instruction for use advises taking the tablets strictly according to the scheme and not allowing the passes. It is important to consider that diarrhea and vomiting are equivalent to the fact that the dose has not been accepted, this reduces the effectiveness of the entire treatment.

- angioedema.   In women with such   The diagnosis of taking the drug increases the risk of worsening of the symptoms of the disease.

Admission of hormonal contraceptives such as "Claira" should be accompanied by regular delivery of tests, because there is information about the negative effect of the drug on certain indicators of laboratory tests.